HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

European Commission Kicks Off 2023 With Batch of Novel Food Approvals

Executive Summary

The European Commission has paved the way for some innovative dietary supplement launches in 2023 with the authorization of eight novel food applications.

You may also be interested in...



EU Novel Food Approvals: Yes To Vit D Mushroom Powder, No To New Zinc Source

Two novel food applications were recently reviewed by the European Food Safety Authority, with one from Monterey Mushrooms for vitamin D2 mushroom powder approved, and another from Hamari Chemicals for a new source of zinc rejected. 

Nestlé Partner Valbiotis Hails Trial Results For Prediabetes Supplement

Valbiotis and Nestlé Health Science plan to launch in 2024 a dietary supplement targeted at sufferers of prediabetes and type-2 diabetes following positive results from a recent study which showed the product's efficacy on key markers of glucose metabolism.

Pierre Fabre Takes Stake In French Women's Health Start-Up

France's Pierre Fabre is enhancing its presence in the women's health market by taking a stake in dietary supplements and cosmetics firm MiYé.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153246

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel